Literature DB >> 19901173

Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS).

Joshua Z Willey1, Qiang Xu, Bernadette Boden-Albala, Myunghee C Paik, Yeseon Park Moon, Ralph L Sacco, Mitchell S V Elkind.   

Abstract

OBJECTIVE: To explore the relationship between lipid profile components and incident ischemic stroke in a stroke-free prospective cohort.
DESIGN: Population-based prospective cohort study.
SETTING: Northern Manhattan, New York. PATIENTS: Stroke-free community residents. Intervention As part of the Northern Manhattan Study, baseline fasting blood samples were collected on stroke-free community residents followed up for a mean of 7.5 years. MAIN OUTCOME MEASURES: Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals for lipid profile components and ischemic stroke after adjusting for demographic and risk factors. In secondary analyses, we used repeated lipid measures over 5 years from a 10% sample of the population to calculate the change per year of each of the lipid parameters and to impute time-dependent lipid parameters for the full cohort.
RESULTS: After excluding those with a history of myocardial infarction, 2940 participants were available for analysis. Baseline high-density lipoprotein cholesterol, triglyceride, and total cholesterol levels were not associated with risk of ischemic stroke. Low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol levels were associated with a paradoxical reduction in risk of stroke. There was an interaction with use of cholesterol-lowering medication on follow-up, such that LDL-C level was only associated with a reduction in stroke risk among those taking medications. An LDL-C level greater than 130 mg/dL as a time-dependent covariate showed an increased risk of ischemic stroke (adjusted hazard ratio, 3.81; 95% confidence interval, 1.53-9.51).
CONCLUSIONS: Baseline lipid panel components were not associated with an increased stroke risk in this cohort. Treatment with cholesterol-lowering medications and changes in LDL-C level over time may have attenuated the risk in this population, and lipid measurements at several points may be a better marker of stroke risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901173      PMCID: PMC2830863          DOI: 10.1001/archneurol.2009.210

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  41 in total

1.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

2.  High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study.

Authors:  D Tanne; S Yaari; U Goldbourt
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

3.  Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups.

Authors:  D L Tirschwell; N L Smith; S R Heckbert; R N Lemaitre; W T Longstreth; B M Psaty
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

4.  Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study.

Authors:  D E Kargman; C Tuck; L Berglund; I F Lin; R S Mukherjee; E V Thompson; J Jones; B Boden-Albala; M C Paik; R L Sacco
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

5.  Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.

Authors:  C M Ballantyne; J A Herd; L L Ferlic; J K Dunn; J A Farmer; P H Jones; J R Schein; A M Gotto
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

6.  Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes.

Authors:  N Qizilbash; L Jones; C Warlow; J Mann
Journal:  BMJ       Date:  1991-09-14

7.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study.

Authors:  E Lindenstrøm; G Boysen; J Nyboe
Journal:  BMJ       Date:  1994-07-02

8.  Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; D E Kargman; Q Gu; M C Zamanillo
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  B R Davis; T Vogt; P H Frost; A Burlando; J Cohen; A Wilson; L M Brass; W Frishman; T Price; J Stamler
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more
  30 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

3.  Regional Subclinical Cerebrovascular Disease Is Associated with Balance in an Elderly Multi-Ethnic Population.

Authors:  Joshua Z Willey; Yeseon P Moon; Mandip S Dhamoon; Erin R Kulick; Ahmet Bagci; Noam Alperin; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind
Journal:  Neuroepidemiology       Date:  2018-06-28       Impact factor: 3.282

Review 4.  Vascular risk factors: imaging and neuropathologic correlates.

Authors:  David S Knopman; Rosebud Roberts
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.

Authors:  Aleksandra Pikula; Alexa S Beiser; Jing Wang; Jayandra J Himali; Margaret Kelly-Hayes; Carlos S Kase; Qiong Yang; Sudha Seshadri; Philip A Wolf
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

6.  Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox.

Authors:  Joshua Z Willey; Carlos J Rodriguez; Yeseon Park Moon; Myunghee C Paik; Marco R Di Tullio; Shunichi Homma; Ralph L Sacco; Mitchell S V Elkind
Journal:  Ann Epidemiol       Date:  2012-03-15       Impact factor: 3.797

Review 7.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

8.  Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study.

Authors:  Joshua Z Willey; Carlos J Rodriguez; Richard F Carlino; Yeseon Park Moon; Myunghee C Paik; Bernadette Boden-Albala; Ralph L Sacco; Marco R DiTullio; Shunichi Homma; Mitchell S V Elkind
Journal:  Am Heart J       Date:  2011-05       Impact factor: 4.749

9.  Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Authors:  Adrien Boillot; Ryan T Demmer; Ziad Mallat; Ralph L Sacco; David R Jacobs; Joelle Benessiano; Alain Tedgui; Tatjana Rundek; Panos N Papapanou; Moïse Desvarieux
Journal:  Atherosclerosis       Date:  2015-07-22       Impact factor: 5.162

10.  Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study.

Authors:  Joshua Z Willey; Hannah Gardener; Yeseon P Moon; Mitsuhiro Yoshita; Charles DeCarli; Ying Kuen Cheung; Ralph L Sacco; Mitchell S V Elkind; Clinton B Wright
Journal:  Cerebrovasc Dis       Date:  2014-07-12       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.